F&P Healthcare underperforming, but there's upside to come

F&P Healthcare underperforming, but there's upside to come
Rebecca Howard
Fisher & Paykel Healthcare may be underperforming the S&P NZX50 of late, but there looks to be plenty of upside.  There are two main reasons. First, countries are battling new outbreaks of covid-19. Second, its equipment is now in place to treat a wide variety of respiratory ailments — not just covid. Hospital products make up around 75 percent of its operating revenue. The stock jumped 48 percent in 2020 as it ramped up manufacturing capacity and hired scores of new staff to meet demand for its hospital hardware pr...

More Editor's Picks

The kiwi dollar is falling prey to the bears
Economy

The kiwi dollar is falling prey to the bears

The only worst performer is the Norwegian krone.

Rebecca Howard 26 Jul 2024
Santana Minerals gains +3.05% in NZX debut
Markets

Santana Minerals gains +3.05% in NZX debut

The company has ambitious plans for a new gold mine in Otago.

Rebecca Howard 25 Jul 2024
Action against Hawkins directors stalled
Property

Action against Hawkins directors stalled

Proceedings by the failed group's liquidators relate to a leaky building claim.

Maria Slade 24 Jul 2024
Stephen Tindall supports Warehouse takeover offer
Retail

Stephen Tindall supports Warehouse takeover offer

Bid from Australian private equity firm values shares at between $1.50 and $1.70.